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Abstract
Background: Unprovoked superficial thrombophlebitis and subsequent venous thromboembolism are well-
described albeit rare presenting features of advanced visceral malignancy that often manifest too late for curative
intervention to be beneficial.
Case Presentation: We present the first reported case of early gastric carcinoma presenting with these
paraneoplastic phenomena in an otherwise healthy farmer. The early presentation allowed for a curative partial
gastrectomy, which itself was complicated by the presence of a deep vein thrombosis extending into the inferior
vena cava. Fortunately, stabilization of the clot allowed for surgery to proceed without the need for a caval filter.
The patient was referred for adjuvant chemotherapy and has since made an excellent recovery.
Conclusions: This case provides new evidence for the presentation of superficial thrombophlebitis in early gastric
carcinoma and the potential for curative surgery in such instances. A high index of suspicion and a prompt
diagnostic workup are essential for timely planning and execution of surgery in these early albeit rare
presentations.
Background
Unlike the well-established association of spontaneous
venous thromboembolism (VTE) with occult neoplasia,
single episodes of unprovoked superficial thrombophle-
bitis have been suggested not to be associated with
malignancy [1]. In contrast, the historically significant
Trousseau syndrome (i.e. migratory thrombophlebitis) is
a well-described association of advanced malignancy -
particularly of pancreatic and pulmonary tumours [2].
The mechanism of this paraneoplastic phenomenon is
unknown but has been linked to the late stage of these
tumours at presentation, which in all reported cases to
date, has precluded any form of curative intervention in
these patients [3,4].
Case presentation
A 41-year-old farmer with no significant past medical
history presented to Casualty with acute, severe pain
over the medial aspect of his right leg and thigh. Exami-
nation revealed exquisitely tender cord-like thickening
along the distribution of the long saphenous vein. The
patient firmly denied external trauma but an infective
cause of the inflammation was presumed ‘until proven
otherwise’.
Intravenous penicillin and flucloxacillin were adminis-
tered but the inflammation persisted for a further three
days. During this time, routine blood tests revealed a
microcytic anemia (hemoglobin 9.3 g/dL, mean corpus-
cular volume 70 fL) of unclear etiology, suggesting the
need for an esophagogastroduodenoscopy (EGD) to
exclude upper gastrointestinal tract bleeding. Concur-
rently, acute swelling of his right calf prompted a duplex
ultrasound scan (USS), which revealed a deep vein
thrombosis (DVT) with vague suggestion of extension
up to the iliac veins. The patient was therefore switched
from his prophylactic regimen of low molecular weight
heparin (LMWH; 5000 units of subcutaneous dalteparin
sodium, once daily) to a therapeutic regimen (15000
units, once daily).
The EGD unexpectedly revealed an annular growth
around the pylorus partially obstructing the gastric out-
let. Biopsy at endoscopy revealed a primary gastric ade-
nocarcinoma. A contrast CT scan demonstrated
mucosal confinement of the tumour with no evidence of
regional lymph node involvement or distant metastasis
(Figure 1). In addition, the CT confirmed thrombosis
within the right femoral vein with extension into the
lower inferior vena cava (IVC) to just below the renal
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Clinical signs of an obstructed IVC were also apparent
in the form of dilated superficial lower abdominal veins
and a positive Harvey’s sign. Nevertheless, the normal
renal function and absence of microscopic haematuria
supported non-involvement of the renal veins by
the DVT.
In anticipation of surgery, anticoagulation was main-
tained with therapeutic-dose LMWH. A vascular surgi-
cal consult advised against the placement of an IVC
filter as the relatively prolonged confinement of the
DVT and therapeutic heparinization made further
extension or dislodgement unlikely. A partial gastrect-
omy was performed with added precaution taken during
dissection around the IVC to avoid thrombus dislodge-
ment. Histology of the resected specimen confirmed a
diffuse-type adenocarcinoma with marked acute and
chronic inflammation but no lymph node involvement
(i.e. T2N0MX or Stage I disease). The patient was
subsequently referred for adjuvant chemotherapy and at
6-month follow-up, displayed no signs or symptoms of
recurrent disease.
Conclusions
Although the natural progression of our patient’ss u p e r -
ficial thrombophlebitis cannot be extrapolated (i.e. to
ascertain if it was truly isolated or migratory), this is
nonetheless the first reported case of early gastric cancer
presenting with this phenomenon and subsequently
amenable to curative surgery. The other significant fea-
ture of our case was the development of DVT, which is
similarly unusual in the early stages of malignancy [5],
and occurred despite prophylactic heparinization at
admission.
The propagation of DVT to the IVC initially posed a
challenge to the surgical management of our patient’s
gastric carcinoma, as it was unclear whether the risks of
deploying a caval filter were warranted prior to major
Figure 1 Contrast computed tomography reconstruction illustrating pyloric tumour (arrows) with consequent gastric outlet
obstruction. No regional lymphadenopathy or distant metastases were noted.
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involving 6376 patients revealed that prophylactic IVC
filters for gastric surgery did not reduce the risk of pul-
monary embolism (PE) but resulted in filter-related
complications such as filter migration (e.g. into the
heart or pulmonary arteries), insertion-site thrombosis
and IVC thrombosis [6]. A study by Deguchi et al simi-
larly demonstrated that the addition of IVC filters to
anticoagulant therapy did not significantly reduce the
risks of perioperative patients with VTE prior to surgery
[7]. It also described occurrences such as major filter
migration, persistent attached thrombosis and connec-
tion failure. Apart from filter dislocation, complications
such as catheter fracture, catheter-related infection and
critical IVC occlusion by massive thrombus post-tumour
resection (i.e. necessitating open IVC ligation) have also
been reported with the use of temporary filters [8].
Nevertheless, it is recommended that when the use of
such filters is imperative, they should be removed as
soon as the risk of VTE has passed [9].
We were reminded that proximal propagation of stable
DVTs after two weeks was highly unlikely, thereby negating
the risks of filter insertion. The evidence supporting this
includes a study by MacDonald et al, in which 91% of all
DVT propagation occurred within 2 weeks of initial diagno-
sis, leading to the authors’ suggestion that follow-up after
2 weeks may be unnecessary [10]. Similarly, Masuda et al
suggested a low likelihood of clot propagation after the first
2 weeks from DVT diagnosis, suggesting serial duplex ima-
ging weekly for the first 2 weeks, with an optional repeat
scan at 4 weeks to confirm clot lysis [11]. In slight contrast,
the most recent evidence by Lautz et al demonstrated that
43% of DVT propagation (or PE) occurred within the initial
2 weeks; and 71% within the first 3 months [12]. In our
case, clinical evidence (e.g. lack of haematuria or altered
urine output which may have indicated clot extension to
renal veins) and contrast CT imaging added to the reassur-
ance of clot stability.
The stability of our patient’st h r o m b u si sv e r yl i k e l y
attributable to the full therapeutic heparinization admi-
nistered upon DVT diagnosis, the efficacy of which has
been proven on many occasions. A study of DVT out-
c o m e sb yG i l l e te ta ls h o w e dn oV T Ee x t e n s i o no r
recurrence within the therapeutic anticoagulation period
Figure 2 Contrast computed tomography of the pelvis demonstrating thrombosis (black arrow) within the lower inferior vena cava,
just before the abdominal aortic bifurcation (white arrow).
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[13]. Schwarz et al demonstrated a DVT propagation
rate of 0% (i.e. despite a recurrence rate of 1.9% at
3 weeks) with therapeutic heparinization and compres-
sion therapy for 10 days, versus a 25% rate of DVT pro-
gression with compression alone (P = 0.0002) [14]. In
support of this, Lautz’s study showed a VTE recurrence
rate of 30% in patients receiving no anticoagulation,
27% in those receiving only prophylactic anticoagulation,
and 12% in those receiving therapeutic anticoagulation
(P = 0.0003). Together with a previous history of VTE,
lack of therapeutic anticoagulation was shown to be an
independent predictor of VTE recurrence. Even during
follow-up, therapeutic anticoagulation resulted in a DVT
resolution rate of 61.2%, compared to 40.0% for prophy-
lactic anticoagulation and 41.0% for no anticoagulation
(P = 0.003) [12]. Considering our patient’s thrombophle-
bitic presentation, his initiation upon prophylactic
LMWH may have been an oversight of the admitting
medical team. Nonetheless, the degree to which he
would have benefited from therapeutic heparinization
during the first three days of admission remains
unknown.
In conclusion, this case provides new evidence for the
presentation of superficial thrombophlebitis in early gas-
tric carcinoma and the potential for curative surgery in
such instances. A high index of suspicion and a prompt
diagnostic workup are essential for timely planning and
execution of surgery in these early albeit rare presenta-
tions. For resectable malignancy associated with DVT
extending up to the IVC, we support a conservative
approach (i.e. therapeutic heparinization) until surgery,
provided that surveillance can demonstrate adequate clot
stabilization over two weeks. Invariably, if DVT occurs
on a suspected background of malignancy, therapeutic-
dose heparin should be used as the sole means of
anticoagulation until the need for surgery is excluded (or
surgery is performed), before warfarin is commenced.
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